Skip to content

Frontlight ResearchEarly access

Institution

Navamindradhiraj University

Bangkok, ThailandWebsite

Also known as: University of Bangkok Metropolis · มหาวิทยาลัยนวมินทราธิราช · NMU

2running trials
2,563publications (OpenAlex)

Running trials

Active, not recruiting
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT05785767· Phase 2/3· Regeneron Pharmaceuticals· Source
Active, not recruiting
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT05248646· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

Registry name variants (2)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Navamindradhiraj University
Dusit, Bangkok 10300
1 trial
- NCT05785767A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
Navamindradhiraj University - Site #174
Bangkok, 10300
1 trial
- NCT05248646Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

Institution data: ROR 01qkghv97 (CC0-1.0)Updated 3 Nov 2026

Report an error

Navamindradhiraj University: trials and research groups – Frontlight Research